Four laboratories are routinely responsible for SARS-CoV-2 PCR testing within the Northern DHB Region of New Zealand: LabPLUS Auckland City Hospital, Auckland DHB (Site A); Labtests, Community Pathology Services Provider (Site B); Middlemore Hospital, Counties Manukau DHB (Site C); and North Shore Hospital, Waitematā DHB (Site D). A retrospective review of laboratory data was undertaken for all SARS-CoV-2 PCR tests performed by these sites between 12 February 2020 (the date SARS-CoV-2 PCR testing commenced in the Northern DHB Region, at Site A) and 8 June 2020. Extracted laboratory data from each site for the above study period included: total number of samples tested; sample types; collection dates; SARS-CoV-2 PCR results; and Ct values for positive results. A variety of in-house and commercial SARS-CoV-2 PCR testing platforms were used by the four study sites during the study period. A comparison of Ct values between assays and targets was not an aim of the present study, as this has already been undertaken elsewhere [see local and regional external quality assurance (EQA) program reports], and thus data on the individual assays and targets used was not collected.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.